Literature DB >> 26724922

Structure-activity relations of leucine derivatives reveal critical moieties for cellular uptake and activation of mTORC1-mediated signaling.

Shushi Nagamori1, Pattama Wiriyasermkul1, Suguru Okuda1, Naoto Kojima2, Yoshiyuki Hari3, Shigeki Kiyonaka4,5, Yasuo Mori4,5, Hideyuki Tominaga6, Ryuichi Ohgaki1, Yoshikatsu Kanai7.   

Abstract

Among amino acids, leucine is a potential signaling molecule to regulate cell growth and metabolism by activating mechanistic target of rapamycin complex 1 (mTORC1). To reveal the critical structures of leucine molecule to activate mTORC1, we examined the structure-activity relationships of leucine derivatives in HeLa S3 cells for cellular uptake and for the induction of phosphorylation of p70 ribosomal S6 kinase 1 (p70S6K), a downstream effector of mTORC1. The activation of mTORC1 by leucine and its derivatives was the consequence of two successive events: the cellular uptake by L-type amino acid transporter 1 (LAT1) responsible for leucine uptake in HeLa S3 cells and the activation of mTORC1 following the transport. The structural requirement for the recognition by LAT1 was to have carbonyl oxygen, alkoxy oxygen of carboxyl group, amino group and hydrophobic side chain. In contrast, the requirement for mTORC1 activation was more rigorous. It additionally required fixed distance between carbonyl oxygen and alkoxy oxygen of carboxyl group, and amino group positioned at α-carbon. L-Configuration in chirality and appropriate length of side chain with a terminal isopropyl group were also important. This confirmed that LAT1 itself is not a leucine sensor. Some specialized leucine sensing mechanism with rigorous requirement for agonistic structures should exist inside the cells because leucine derivatives not transported by LAT1 did not activate mTORC1. Because LAT1-mTOR axis is involved in the regulation of cell growth and cancer progression, the results from this study may provide a new insight into therapeutics targeting both LAT1 and leucine sensor.

Entities:  

Keywords:  Amino acid signaling; Amino acid transporter; LAT1; Leucine; Structure–activity relationship; mTOR

Mesh:

Substances:

Year:  2016        PMID: 26724922     DOI: 10.1007/s00726-015-2158-z

Source DB:  PubMed          Journal:  Amino Acids        ISSN: 0939-4451            Impact factor:   3.520


  21 in total

1.  LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates.

Authors:  Arik A Zur; Huan-Chieh Chien; Evan Augustyn; Andrew Flint; Nathan Heeren; Karissa Finke; Christopher Hernandez; Logan Hansen; Sydney Miller; Lawrence Lin; Kathleen M Giacomini; Claire Colas; Avner Schlessinger; Allen A Thomas
Journal:  Bioorg Med Chem Lett       Date:  2016-09-03       Impact factor: 2.823

2.  L-type amino acid transporter 1 promotes proliferation and invasion of human chorionic trophoblast and choriocarcinoma cells through mTORC1.

Authors:  Wenping Luo; Hongmei Zhang; Yan Zhang; Panpan Liang; Xiaojie Wang; Jing Ma; Dongmei Tan; Yi Tan; Jinlin Song; Ping Ji; Tianyu Zhao
Journal:  Am J Transl Res       Date:  2020-10-15       Impact factor: 4.060

3.  18F-Branched-Chain Amino Acids: Structure-Activity Relationships and PET Imaging Potential.

Authors:  Matthew B Nodwell; Hua Yang; Helen Merkens; Noeen Malik; Milena Čolović; Rainer E Martin; François Bénard; Paul Schaffer; Robert Britton
Journal:  J Nucl Med       Date:  2019-01-25       Impact factor: 10.057

4.  Reevaluating the Substrate Specificity of the L-Type Amino Acid Transporter (LAT1).

Authors:  Huan-Chieh Chien; Claire Colas; Karissa Finke; Seth Springer; Laura Stoner; Arik A Zur; Brooklynn Venteicher; Jerome Campbell; Colton Hall; Andrew Flint; Evan Augustyn; Christopher Hernandez; Nathan Heeren; Logan Hansen; Abby Anthony; Justine Bauer; Dimitrios Fotiadis; Avner Schlessinger; Kathleen M Giacomini; Allen A Thomas
Journal:  J Med Chem       Date:  2018-08-10       Impact factor: 7.446

5.  FTY720-induced endocytosis of yeast and human amino acid transporters is preceded by reduction of their inherent activity and TORC1 inhibition.

Authors:  Céline Barthelemy; Abdoulaye Oury Barry; Laure Twyffels; Bruno André
Journal:  Sci Rep       Date:  2017-10-23       Impact factor: 4.379

6.  Discovery of Potent Inhibitors for the Large Neutral Amino Acid Transporter 1 (LAT1) by Structure-Based Methods.

Authors:  Natesh Singh; Mariafrancesca Scalise; Michele Galluccio; Marcus Wieder; Thomas Seidel; Thierry Langer; Cesare Indiveri; Gerhard F Ecker
Journal:  Int J Mol Sci       Date:  2018-12-21       Impact factor: 5.923

7.  L amino acid transporter structure and molecular bases for the asymmetry of substrate interaction.

Authors:  Ekaitz Errasti-Murugarren; Joana Fort; Paola Bartoccioni; Lucía Díaz; Els Pardon; Xavier Carpena; Meritxell Espino-Guarch; Antonio Zorzano; Christine Ziegler; Jan Steyaert; Juan Fernández-Recio; Ignacio Fita; Manuel Palacín
Journal:  Nat Commun       Date:  2019-04-18       Impact factor: 14.919

Review 8.  L-Type amino acid transporter 1 as a target for drug delivery.

Authors:  Elena Puris; Mikko Gynther; Seppo Auriola; Kristiina M Huttunen
Journal:  Pharm Res       Date:  2020-05-06       Impact factor: 4.200

9.  Beneficial Effects of Acetyl-DL-Leucine (ADLL) in a Mouse Model of Sandhoff Disease.

Authors:  Ecem Kaya; David A Smith; Claire Smith; Barry Boland; Michael Strupp; Frances M Platt
Journal:  J Clin Med       Date:  2020-04-08       Impact factor: 4.964

10.  Tyrosine-Chlorambucil Conjugates Facilitate Cellular Uptake through L-Type Amino Acid Transporter 1 (LAT1) in Human Breast Cancer Cell Line MCF-7.

Authors:  Piman Pocasap; Natthida Weerapreeyakul; Juri Timonen; Juulia Järvinen; Jukka Leppänen; Jussi Kärkkäinen; Jarkko Rautio
Journal:  Int J Mol Sci       Date:  2020-03-20       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.